Botanisol
Nearby engineering companies
N Gateway Drive, Phoenix
Phoenix 85034
N. Gateway Drive, Phoenix
North Gateway Drive, Gilbert
You may also like
Autonomous disease detection kiosks.
Fifty Foot Falls In Arizona,USA
In addition to being one of the top rated Octane Launchpad companies of all time, and THE ONLY out of 30 Techstars Air Force companies to receive investment from Techstars Ventures, our MedTech Innovator West Coast Pitch scores are in and we're pleased to report that:
65% of all expert judges called our technology "transformational". 62% of all judges gave us the maximum possible "value to patient" score. 46% of all judges gave us the maximum possible management team score. 15% of all judges gave us the maximum possible total opportunity score! That means that 15% of all MedTech Innovator judges deemed our company consistent with the best startups they've ever seen!
Did you notice Botanisol's front page coverage in the Arizona Republic? What about our interview on the Hill? Or our spotlight on Voice of America, Russia? How about channel 3 TV? It's been a wild ride!
The Botanisol test has not been reviewed, approved, or authorized by the FDA and is not currently available in the United States.
https://lnkd.in/gRrMnRnE
https://lnkd.in/gZpAanZy
https://lnkd.in/g3dFsaRf
Good news! Botanisol Analytics was chosen from over 1,000 applicants to participate in MedTech Innovator's road show! The following experts specifically selected us for further discussion: Genentech, Sunrise Labs, Edwards Lifesciences, WL Gore and Associates, Khosla Ventures, Baymed Venture Partners, Hunwell Lake Ventures, and Arizona Tech Investors, just to name a few!
Botanisol Analytics CEO Dave Talenfeld was invited to give a presentation to a joint meeting of the French Academy of Pharmacy and the Israeli Society for Medication and Vaccine Safety. You can watch him discuss the future of Autonomous Testing Kiosks™ (ATKs™) in retail pharmacies below.*
https://lnkd.in/gixXE94B
*The Botanisol test has not been reviewed, approved, or authorized by the FDA and is not currently available in the United States. All performance estimates are internal and preliminary.
Botanisol Analytics Presentation to the French Academy of Pharmacy 7 February 2023 Dave Talenfeld, CEO, explains how any biological test can be run in 6 sec, using IA and machine learning
Good news! Botanisol Analytics CEO Dave Talenfeld received the Judge's Choice Award from a panel of venture capitalists at Octane's annual Medical Innovation Forum! The award is in recognition of Botanisol's unique potential to transform the way patients are diagnosed with infectious disease. Sponsored by the likes of Medtronic, Edwards, Allergan, and City of Hope, OMIF is the largest event of its kind in California.
**The Botanisol test has not been reviewed, approved, or authorized by the FDA and is not currently available in the United States.
Botanisol Analytics CEO Dave Talenfeld was a guest speaker at Qatar's first ever E-Commerce Hackathon! You can listen to him discuss the future of "radically convenient" disease screening below!
https://youtu.be/QLJ1YaM7a18
We're excited to announce that we'll be pitching the main stage at the Tech Innovation Forum!. We're the only medtech company to do so, addressing an audience of 750 investors, VCs, strategic partners and government officials!
https://octaneoc.org/tif-startup/?utm_campaign=TIF%202022&utm_medium=email&_hsmi=210079016&_hsenc=p2ANqtz-_dwZHxwlpZyHNvlyUolRtmKr7kMO94lcUF-vZ9a6qY1FzuQyiMrbErMmrSIyNN4tbq6Bya51Yi8MoiiIQYiKXOZ8-H_Q&utm_content=210079016&utm_source=hs_email
Presenting Companies at Tech Innovation Forum (TIF) • Octane Present your tech company in front of investors, strategic advisors, entrepreneurs, and more at this year’s Tech Innovation Forum (TIF).
Following close on the heels of our presentation at South by Southwest, we're pleased to announce our selection for the Southern California Biomedical Council's annual conference! Join us at the Hyatt Regency Long Beach March 22nd and 23rd!
https://www.eventbrite.com/e/5th-socalbio-digital-health-conference-tickets-149369102005
Botanisol Analytics presented at South by Southwest (SXSW) in Austin Texas! Featured are Zach Brooks and David Smith with pitch judge Lance Armstrong!
You're familiar with ATMs?
This is the ATK (Autonomous Testing Kiosk).
https://youtu.be/fJpuXnReq2U
We at Botanisol Analytics are very proud to announce our partnership with Invest Africa Global and Evergreen SADC to field test our technology for the Ministry of Health and Social Services of the Republic of Namibia!!!
Botanisol Analytics has been featured in the Magazine of the German Federal Police! ""Autonome Kioske zum Testen von Krankheiten."
Botanisol Analytics is a South by Southwest (SXSW) pitch finalist! We'll be presenting to a live audience of high-profile media, venture capital investors, and expert judges including industry moguls like Jim Breyer (Breyer Capital), Stacy Feld (Johnson & Johnson), Lance Armstrong (Next Ventures), Deena Shakir (Lux Capital), and former Walmart CEO Marc Lore. Watch Zach Brooks, PhD live in Austin on Friday March 11th!
https://lnkd.in/eUjNjsHB
Finalists Announced for the 2022 SXSW Pitch Startup Event Explore the list of 45 companies from around the world selected for SXSW Pitch.
Botanisol Analytics, in addition to having raised a million dollars from K4 to date, is now the first company ever invited to present to both of Keiretsu Forum's two nationwide investor expos! See you there. :)
Botanisol Analytics is now a Mass Robotics company. Visit our Boston office to experience autonomous disease detection in action.
Botanisol on the cover of Arizona Business Magazine, named as a Fast Lane Awardee by the Arizona BioIndustry Association (AZBio).
Watch the presentation on ABC 15 at 4pm Arizona time (7pm EST) today, Sunday, October 3rd or at:
https://www.azbio.org/celebrating-life-science-2021
Like and share! David Talenfeld Ayse Ulgen University of Arizona The University of Arizona Wyant College of Optical Sciences Tech Launch Arizona
Botanisol Analytics named University of Arizona Tech Launch Arizona's Startup of the Year 2021!
David Talenfeld Ayse Ulgen
A special feature on our Director of Research, Dr. Ayse Ulgen.
https://news.stonybrook.edu/stony-brook-matters/uncategorized/fulbright-scholar-ayse-ulgen-ms-96-phd-01-looks-to-revolutionize-public-health-systems-around-the-world/
Fulbright Scholar Ayse Ulgen, MS '96, PhD '01 Looks to Revolutionize Public Health Systems Around the World | Stony Brook Matters Alumni SpotlightMedicine and ResearchStony Brook MattersUncategorized Fulbright Scholar Ayse Ulgen, MS ’96, PhD ’01 Looks to Revolutionize Public Health Systems Around the World 7 days ago7 min read Ayse Ulgen’s work knows no borders. Born in Cyprus, Ulgen’s career in higher education and ac...
We're proud to announce a large scale study with Beth Israel Deaconess Medical Center, a Harvard Medical School Hospital.
https://www.prweb.com/releases/botanisol_analytics_performs_validation_process_of_rapid_digital_covid_19_screener_with_leading_hospital/prweb17754590.htm
Botanisol Analytics Performs Validation Process of Rapid Digital COVID-19 Screener with Leading Hospital BOSTON (PRWEB) February 24, 2021 -- Beth Israel Deaconess Medical Center generates data and expands capabilities of device with machine learning to detect SARS-CoV-2
Botanisol Analytics is now in partnership with the world's leading spectrometer maker to manufacture up to 100,000 of its 785+ systems per year.
https://bit.ly/3pN4ppP
Botanisol Analytics and Ocean Insight Introduce First Laser Virus Screener Botanisol Analytics, the cutting-edge biological threat detection technology company, and Ocean Insight, the leading maker of compact, high-performance spectrometers, today announced a partnership to develop and introduce the world’s first portable laser virus screener.
We're honored to be recognized by the Flinn Foundation and excited to take our place on the Arizona Bioscience Steering Committee!
https://bit.ly/3byh6Qp
Seven Arizona bio startups earn $30K through Flinn Foundation entrepreneurship program Five Phoenix, two Tucson firms to receive personalized learning plan, other benefits Artificial intelligence to assist Alzheimer’s disease caregivers, rapid virus screeners, a headband to monitor for concussions, and new technologies for surgeries and drug discovery are some of the innovations of ...
Click here to claim your Sponsored Listing.
Category
Website
Address
6 Liberty Square
Boston, MA
02109
Boston
Paul is the co-founder and CEO of Mercy Bioanalytic. He began his career in 1986 as an investment banker with Citibank and Donaldson, Lufkin & Jenrette. He then served as the Presi...
139A Charles Street #315
Boston
Our novel family of Janus base nanomaterials is based on DNA nanotechnology.
27 Drydock Avenue
Boston, 02210
A next-generation biosecurity platform, by Ginkgo Bioworks.
Boston, 02210
Clinical-stage biopharma company dedicated to developing therapeutics for rare diseases that affect bone health & blood vessel function. Our lead candidate, INZ-701, is in clinical...
Boston, 02109
At Cora Care, we are developing prognostic tools to help pet owners take care of their pets.
Boston, 02210
Innovating to transform the treatment of devastating diseases through intracellular therapeutics.
99 High Street, 30th Floor
Boston, 02110
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for central nervous system, ...
Boston, 02135
NanoView Biosciences is focused on enabling worldwide life science researchers to better understand the biological role of extracellular vesicles, including exosomes and viral vect...
Boston
Welcome to Pronova, we are here to help you care for your pets by pioneering a new standard of care.
121 Seaport Boulevard
Boston, 02210
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to ...